INCREASED SV2A-PET AND EXCITATORY POSTSYNAPTIC POTENTIAL CORRELATES WITH RELEASE OF CSF NEUROGRANIN AND TAU IN APP KNOCK-IN MICE (ID 2268)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF
Audio MP3

Audio MP3

Hide

Previous ePoster
MOLECULAR COMPOSITION OF ENTORHINAL SYNAPSES IN PRIMARY AGE-RELATED TAUOPATHY AND ALZHEIMER’S DISEASE (ID 2267)

Next ePosters
CHRONIC IN VIVO ALTERATIONS OF AΗ-Α PEPTIDE LEVELS PERTURB SYNAPTIC PLASTICITY AND IMPACT SPATIAL MEMORY. (ID 2271)
TRANSCRIPTOME ANALYSIS OF HIPPOCAMPUS OF APP KNOCK-IN ALZHEIMER MOUSE MODELS REVEALS AUTOPHAGY IMPAIRMENT LINKED WITH SYNAPTIC DYSFUNCTION (ID 2272)
AMYLOID SEEDING EMERGES AS A POTENTIAL TARGET FOR THE TREATMENT OF AMYLOIDOSIS (ID 2222)
SYNAPTIC ESTROGEN RECEPTOR ALPHA IMPROVES E46K-AMPLIFIED 3K ALPHA-SYNUCLEIN NEUROPATHOLOGY AND PHENOTYPES IN MICE (ID 2225)
FEASIBILITY AND SAFETY OF SIMULTANEOUSLY IMPLANTING AUTOLOGOUS REGENERATIVE PERIPHERAL NERVE TISSUE TO THE NUCLEUS BASALIS OF MEYNERT AND SUBSTANTIA NIGRA IN PATIENTS WITH PARKINSON’S DISEASE (ID 2227)
APABETALONE BET-INHIBITION AND COGNITION: A MOCA ASSESSMENT IN THE PHASE 3 CVD-OUTCOMES TRIAL BETONMACE (ID 2385)
NO POSTER UPLOADED
BIOMARKER MODELING OF ALZHEIMER'S DISEASE USING IN VIVO BRAAK STAGING (ID 2318)
A MODEL COMBINING TAU PET, BASELINE COGNITION AND NEUROFILAMENT LIGHT OPTIMALLY PREDICTS COGNITIVE DECLINE OVER 24 MONTHS IN AMNESTIC MILD COGNITIVE IMPAIRMENT AND DEMENTIA (ID 2319)
SHORT-TERM PSYCHOLOGICAL IMPACT OF PRECLINICAL AΒ PET DISCLOSURE: PRELIMINARY FINDINGS FROM THE WISCONSIN REGISTRY FOR ALZHEIMER’S PREVENTION (ID 2320)
Α-SYNUCLEIN CONFORMATIONS AS NOVEL BIOMARKERS IN BLOOD OF PD PATIENTS (ID 2322)